Kevin Smith Puno Cabuhat

Mr. Kevin Smith Puno Cabuhat

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 December 2025 in European Journal of Microbiology and Immunology
Verified
Journal Article
Open access
COChristian Joseph Ong
Christian Joseph Ong
OEOluwagbemisola Elizabeth Elesho
Oluwagbemisola Elizabeth Elesho
BBBolorunduro Babatunde Bramwell
Bolorunduro Babatunde Bramwell
KCKevin Smith Puno Cabuhat
Kevin Smith Puno Cabuhat
GBGrace D. Bacalzo
Grace D. Bacalzo
JFJamil Allen Gamboa Fortaleza
Jamil Allen Gamboa Fortaleza
Staphylococcus aureus is a clinically important bacterial pathogen causing infections from superficial skin lesions to life-threatening systemic diseases. The emergence of methicillin-resistant S. aureus (MRSA) has compounded the global health burden, particularly in low- and middle-income countries, as its quorum-sensing (QS) mediated mechanisms contribute to its persistence, resistance, and evasion from host immune responses and antimicrobial treatments. Thus, these features compromise the effectiveness of conventional antibiotics, urging the need for alternative therapeutic approaches. To resolve these issues, several non-antibiotic antibiofilm approaches have been developed. Bacteriophages and phage-derived enzymes show promising specificity in lysing bacterial cells and disrupting biofilms. Antimicrobial peptides (AMPs), with their broad-spectrum activity, destabilize bacterial membranes and modulate immune responses. Monoclonal antibodies can neutralize toxins or inhibit adhesion molecules within biofilms. Phytochemicals have demonstrated activity against QS pathways and efflux pumps. Metal ion chelators like deferiprone interfere with iron acquisition, which is essential for biofilm stability. Nanoparticles (NPs), ranging from metallic and polymeric to lipid-based and cyclodextrin-based systems, enhance drug delivery and biofilm penetration. CRISPR-Cas systems provide precise genome editing to target resistance genes and virulence factors. Rhamnolipids disrupt biofilm matrix integrity, while enzymes such as dispersin B degrade extracellular polymeric substances. Photodynamic and laser therapies offer localized disruption of biofilm structures through oxidative stress. Collectively, this review offers a transformative complementary approach to traditional antibiotics, enhancing treatment efficacy while potentially reducing the emergence of resistance. Continued research on delivery systems, safety profiles, and synergistic combinations will be pivotal for their clinical translation against S. aureus infections.

19 August 2022 in Journal of Pure and Applied Microbiology
Verified
Journal Article
Open access
KCKevin Smith Puno Cabuhat
Kevin Smith Puno Cabuhat
LMLlewelyn Sotto Moron-Espiritu
Llewelyn Sotto Moron-Espiritu
Quorum sensing (QS) is a type of cell-to-cell communication that is influenced by an increase in signaling molecules known as autoinducers, which is correlated to the increase in the density of microbial communities. In this review, we aim to discuss and provide updates on the different signaling molecules used by Escherichia coli, such as acyl-homoserine lactone (AHL), autoinducer-2 (AI-2), and indole to influence key phenotypes such as antibiotic drug resistance, biofilm formation, and motility during quorum sensing. Based on the literature, E. coli signaling molecules have different functions during cell-to-cell communication such that the increase in AHL and indole was found to cause the modulation of antibiotic resistance and inhibition of biofilm formation and motility. Meanwhile, AI-2 is known to modulate biofilm formation, antibiotic resistance, and motility. On the other hand, in the existing literature, we found that various plants possess phytochemicals that can be used to alter QS and its downstream key phenotypes such as biofilm formation, swimming and swarming motility, and genes related to motility, curli and AI-2 production. However, the exact physiological and molecular mechanisms of these natural compounds are still understudied. Understanding the mechanisms of those phytochemicals during QS are therefore highly recommended to conduct as a necessary step for future scholars to develop drugs that target the actions of QS-signaling molecules and receptors linked to antibiotic resistance, biofilm formation, and motility without putting bacteria under stress, thereby preventing the development of drug resistance.

4 May 2026 in Virulence
Verified
Journal Article
Open access
JFJamil Allen Gamboa Fortaleza
Jamil Allen Gamboa Fortaleza
KCKevin Smith Puno Cabuhat
Kevin Smith Puno Cabuhat
COChristian Joseph Ong
Christian Joseph Ong
Ferdinand Apolonio MortelFerdinand Apolonio Mortel
Ferdinand Apolonio Mortel
GBGrace D. Bacalzo
Grace D. Bacalzo
JNJose Jurel M. Nuevo
Jose Jurel M. Nuevo
Acinetobacter baumannii, once regarded as a low-virulence organism, has emerged as a major global pathogen due to the rapid dissemination of multidrug-resistant (MDR), extensively drug-resistant (X...

31 December 2025 in European Journal of Microbiology and Immunology
Verified
Journal Article
Open access
KCKevin Smith Puno Cabuhat
Kevin Smith Puno Cabuhat
TTTroy Vincent C. Tan
Troy Vincent C. Tan
COChristian Joseph Ong
Christian Joseph Ong
Ferdinand Apolonio MortelFerdinand Apolonio Mortel
Ferdinand Apolonio Mortel
GBGrace D. Bacalzo
Grace D. Bacalzo
JFJamil Allen Gamboa Fortaleza
Jamil Allen Gamboa Fortaleza
Antimicrobial resistance (AMR), particularly in methicillin-resistant Staphylococcus aureus (MRSA), continues to threaten global health due to its multidrug resistance and strong biofilm-forming ability. Antimicrobial peptides (AMPs) have emerged as promising agents against MRSA biofilms because of their diverse origins, structural versatility, and unique modes of action. Natural AMPs derived from animals, plants, fungi, protists, archaea, and bacteria primarily act by disrupting bacterial membranes, interfering with quorum sensing, and downregulating biofilm-related genes such as sarA , icaA , and icaD . Synthetic AMPs, designed through computational modeling and machine learning, demonstrate enhanced stability, reduced toxicity, and improved target specificity. Synergistic AMP–antibiotic combinations, including nisin, indolicidin, and α-MSH analogs with β-lactams, significantly improve antibiofilm efficacy and bacterial clearance. Despite these advances, challenges persist due to peptide instability, enzymatic degradation, cytotoxicity, and limited in vivo validation. Recent developments in nanoparticle, hydrogel, coatings, and nanofiber delivery systems have improved AMP bioavailability and controlled release within biofilms. Continued integration of peptide engineering, nanotechnology, and bioinformatics-driven design offers promising solutions for clinical translation. Overall, AMPs represent a frontier in combating MRSA biofilms and antibiotic resistance, with future research focusing on stability enhancement, resistance prevention, and optimized therapeutic delivery.

30 May 2026 in Tropical Medicine and Health
Verified
Journal Article
Open access
PDF file
RNRahmatullah Nazari
Rahmatullah Nazari
SQShabrina Arifia Qatrannada
Shabrina Arifia Qatrannada
MJMurtaza Jafari
Murtaza Jafari
SASayed Hussain Amiri
Sayed Hussain Amiri
COChristian Joseph Ong
Christian Joseph Ong
DIDon Eliseo Lucero-Prisno III
Don Eliseo Lucero-Prisno III
Introduction: Antimicrobial resistance (AMR) is a critical and escalating public health threat globally, with Southeast Asia facing particularly high burdens due to elevated antimicrobial consumption, fragmented health systems, and uneven regulatory enforcement. Although member states of the Association of Southeast Asian Nations (ASEAN) have introduced AMR-related initiatives aligned with the Global Action Plan on AMR, the regional evidence base remains dispersed, fragmented across sectors, and insufficiently synthesized from a One Health perspective. This scoping review aimed to systematically map implemented AMR interventions across ASEAN countries, characterize their implementation patterns, assess the extent of One Health integration, and identify evidence gaps. Methods: We conducted a scoping review following PRISMA-ScR guidelines. PubMed/MEDLINE, Scopus, and ScienceDirect were searched for empirical studies published between January 1, 2018, and December 31, 2025, that reported the implementation of AMR-related programs, policies, or interventions in ASEAN member states. Data on country, sector, setting, intervention type, One Health pillar, study design, and outcomes were extracted and analyzed using narrative synthesis. Results: Of 9,832 records screened, 57 studies met the inclusion criteria. Evidence was heavily concentrated in three countries: Thailand (n = 15, 26.3%), Singapore (n = 13, 22.8%), and Vietnam (n = 12, 21.1%), accounting for 70.2% of all studies. Critically, no eligible peer-reviewed studies were identified from Brunei Darussalam, while Laos and Cambodia were represented only through disaggregated data from one multi-country surveillance study. The human health sector dominated (86.0%), while only 8.8% of studies adopted integrated One Health approaches, and no studies addressed the environmental sector in isolation. Antimicrobial stewardship was the most common intervention (63.2% of studies), but explicit use of implementation science frameworks was rare. Fifteen studies (26.3%) evaluated multi-component interventions, indicating an emerging shift toward integrated strategies. Most studies employed observational designs (50.9%) and assessed short-term process outcomes rather than sustained resistance reduction. Conclusions: This comprehensive mapping of AMR interventions across all ten ASEAN countries reveals extreme geographical and sectoral inequities. The complete absence of evidence from three member states and the dominance of hospital-based human health interventions underscore the urgent need for targeted investment in underrepresented settings and genuinely integrated One Health approaches. Without such advances, antimicrobial resistance initiatives in ASEAN will remain fragmented and unable to achieve sustained population-level impact.

19 June 2026 in Biology
Verified
Journal Article
Open access
PDF file
COChristian Joseph Ong
Christian Joseph Ong
JFJamil Allen Gamboa Fortaleza
Jamil Allen Gamboa Fortaleza
EREdison D. Ramos
Edison D. Ramos
KCKevin Smith Puno Cabuhat
Kevin Smith Puno Cabuhat
JCJowi Tsidkenu Pili Cruz
Jowi Tsidkenu Pili Cruz
JNJose Jurel M. Nuevo
Jose Jurel M. Nuevo
Methicillin-resistant Staphylococcus aureus (MRSA) remains a significant multidrug-resistant pathogen, frequently associated with persistent infections and biofilm formation, underscoring the urgent need for alternative antimicrobial strategies. Bioactive compounds derived from fungi have attracted considerable attention due to their structural diversity and demonstrated antibacterial activity against MRSA. This study employed a scientometric approach to assess global research trends, thematic evolution, and collaborative networks concerning fungi-derived anti-MRSA compounds. Bibliographic data were collected from the Scopus database, and a total of 1666 English-language articles and reviews published up to 2025 were analyzed using Bibliometrix/Biblioshiny and VOSviewer. The findings indicate a marked increase in research output after 2010, reflecting heightened scientific interest in fungal natural products for MRSA management. China and the United States emerged as leading contributors in terms of publication volume and international collaboration. Thematic analysis revealed a shift from broad antimicrobial screening to more specialized investigations, including antibiofilm activity, secondary metabolites, endophytic fungi, molecular docking, and antimicrobial resistance. Nonetheless, several challenges persist, such as insufficient mechanistic validation, limited toxicity and pharmacokinetic assessments, and a lack of clinically relevant in vivo studies. Overall, the field is increasingly multidisciplinary, integrating microbiology, natural product chemistry, and computational methodologies to advance the discovery of anti-MRSA agents.